Effects of 49 Different Rare Hb Variants on HbA1c Measurement in Eight Methods
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: Previous studies have shown interference with HbA1c measurement from the 4 most common heterozygous Hb variants (HbAS, HbAE, HbAC, and HbAD) with some assay methods. Here we examine analytical interference from 49 different less common variants with 7 different HbA1c methods using various method principles. Methods: Hb variants were screened using the Bio-Rad Variant or Variant II beta thal short program, confirmed by alkaline and acid electrophoresis, and identified by sequence analysis. The Trinity ultra2 boronate affinity high-performance liquid chromatography (HPLC) method and Roche Tinaquant immunoassay were used as primary and secondary comparative methods, respectively, since these methods are least likely to show interference from Hb variants. Other methods included were the Tosoh G7 and G8, Bio-Rad D-10 and Variant II Turbo, Diazyme Enzymatic, and Sebia Capillarys 2 Flex Piercing. To eliminate any inherent calibration bias, results for each method were adjusted using regression verses the ultra2 with nonvariant samples. Each method’s calibration-adjusted results were compared and judged to be acceptable if within the 99% prediction interval of the regression line for nonvariant samples. Results: Almost all variant samples were recognized as such by the ion-exchange HPLC methods by the presence of abnormal peaks or results outside the reportable range. For most variants, interference was seen with 1 or more of the ion-exchange methods. Following manufacturer instructions for interpretation of chromatograms usually, but not always, prevented reporting of inaccurate results. Results: Laboratories must be cautious about reporting results when the presence of a variant is suspected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several hemoglobin variants (e.g., hemoglobins S, C, D, and E) and chemically modified derivatives of hemoglobin interfere with some assay methods (independent of any effects due to shortened RBC survival) (348-350) (for a review, see reference 347).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [350]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Hemoglobin: Molecular, Genetic and Clinical Aspects.
(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-5-820_2 · Cited by 1,006
Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin
Bry, L., Chen, P. C., & Sacks, D. B. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.2.153 · Cited by 523
A Review of Variant Hemoglobins Interfering with Hemoglobin A1c Measurement
Little, R. R., & Roberts, W. L. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300307 · Cited by 311 · cited 2×
“The Tinaquant immunoassay reagents have been shown to produce accurate results in the presence of common heterozygous variants Hb S, C, E, and D.(6) In the current study, a NGSP Secondary Reference Laboratory in Columbia, Missouri, performed analyses using the ultra(2) (Trinity Biotech, Kansas City, MO).”
BackgroundMethodSelf-citationExecutive Summary: Standards of Medical Care in Diabetes—2014
(2014) · Diabetes Care · doi:10.2337/dc14-s005 · Cited by 293
Research works printed but not linked: 2
- World Health Organization, 2011, Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation
- Connolly S, 2013, Clin Chem, 59, A161
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 203
Little, R. R., Rohlfing, C., & Sacks, D. B. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.296962 · Cited by 161
Self-citationGlobal variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
NCD Risk Factor Collaboration (NCD-RisC), Zhou, B., Sheffer, K. E., Bennett, J. E., Gregg, E. W., Danaei, G., Singleton, R. K., Shaw, J. E., Mishra, A., Lhoste, V. P. F., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02610-2 · Cited by 94
Cardiac Troponin T: Only Small Molecules in Recreational Runners After Marathon Completion
Vroemen, W. H. M., Mezger, S. T. P., Masotti, S., Clerico, A., Bekers, O., de Boer, D., & Mingels, A. M. A. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.027144 · Cited by 78
Metadata
- Authors
- Little, R. R., La’ulu, S. L., Hanson, S. E., Rohlfing, C. L., & Schmidt, R. L.
- Affiliations
- University of Missouri (US)
- ARUP Institute for Clinical and Experimental Pathology (US)
- University of Utah (US)
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2015-02-17
- Volume
- 9
- Issue
- 4
- Pages
- 849-856
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC4525651
- OpenAlex
- W2067649070
- Semantic Scholar
- 7d828174ffb22c67d0bbd7f633e53b8e32b2349e
- Cited by
- 83
- References
- 17
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 12 · 2023: 7 · 2022: 10 · 2021: 7 · 2020: 9 · 2019: 4 · 2018: 8 · 2017: 7 · 2016: 4 · 2015: 4
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (UC4DK096587)
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Keywords
- hemoglobin variants, HbA1c testing, analytical interference, HbA1c, ion-exchange HPLC, immunoassay, method comparison, calibration bias, hemoglobin electrophoresis, hemoglobin S, hemoglobin E, hemoglobin C, hemoglobin D
- MeSH terms
- Chromatography, High Pressure Liquid, Electrophoresis, Glycated Hemoglobin, Hemoglobins, Abnormal, Heterozygote, Humans, Immunoassay, Genetic Variation, Reproducibility of Results, Linear Models, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of 49 Different Rare Hb Variants on HbA1c Measurement in Eight Methods. https://app.cochat.ai/papers/10.1177/1932296815572367
- The paper
- Little, R. R., La’ulu, S. L., Hanson, S. E., Rohlfing, C. L., & Schmidt, R. L. (2015). Effects of 49 Different Rare Hb Variants on HbA1c Measurement in Eight Methods. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296815572367
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.